GPATCH8 | G patch domain containing 8 | 17q21.31 | 0.403 | 0.566 | 0
|
USP34 | ubiquitin specific peptidase 34 | 2p16.1-p15 | 0.391 | 0.472 | 0
|
KANSL1 | KAT8 regulatory NSL complex subunit 1 | 17q21.31 | 0.391 | 0.538 | 0
|
RLF | rearranged L-myc fusion | 1p32 | 0.386 | 0.589 | 0
|
TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | Xq13.1 | 0.383 | 0.509 | 0
|
C1orf54 | chromosome 1 open reading frame 54 | 1q21.2 | 0.381 | -0.499 | 0
|
TRAPPC8 | trafficking protein particle complex 8 | 18q12.1 | 0.379 | 0.44 | 0
|
TCP11L2 | t-complex 11, testis-specific-like 2 | 12q23.3 | 0.377 | 0.478 | 0
|
GGT5 | gamma-glutamyltransferase 5 | 22q11.23 | 0.376 | -0.512 | 0
|
RSBN1 | round spermatid basic protein 1 | 1p13.1 | 0.374 | 0.478 | 0
|
BTAF1 | BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa | 10q22-q23 | 0.374 | 0.47 | 0
|
RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 7p13-p12 | 0.373 | -0.563 | 0
|
ZNF292 | zinc finger protein 292 | 6q15 | 0.371 | 0.564 | 0
|
GPBAR1 | G protein-coupled bile acid receptor 1 | 2q35 | 0.365 | -0.486 | 0
|
FBXO11 | F-box protein 11 | 2p16.3 | 0.361 | 0.533 | 0
|
LST1 | leukocyte specific transcript 1 | 6p21.3 | 0.353 | -0.435 | 0
|
GYPC | glycophorin C (Gerbich blood group) | 2q14-q21 | 0.353 | -0.511 | 0
|
PECAM1 | platelet/endothelial cell adhesion molecule 1 | 17q23.3 | 0.352 | -0.504 | 0
|
ZNF654 | zinc finger protein 654 | 3p11.1 | 0.352 | 0.466 | 0
|
CLASP1 | cytoplasmic linker associated protein 1 | 2q14.2-q14.3 | 0.352 | 0.384 | 4e-17
|
SRPK2 | SRSF protein kinase 2 | 7q22-q31.1 | 0.351 | 0.475 | 0
|
LYL1 | lymphoblastic leukemia associated hematopoiesis regulator 1 | 19p13.13 | 0.349 | -0.472 | 0
|
GIMAP5 | GTPase, IMAP family member 5 | 7q36.1 | 0.347 | -0.51 | 0
|
GIMAP1 | GTPase, IMAP family member 1 | 7q36.1 | 0.347 | -0.521 | 0
|
P2RY8 | purinergic receptor P2Y, G-protein coupled, 8 | Xp22.33 and Yp11.3 | 0.339 | -0.433 | 0
|
PHF6 | PHD finger protein 6 | Xq26 | 0.338 | 0.481 | 0
|
CLEC3B | C-type lectin domain family 3, member B | 3p22-p21.3 | 0.331 | -0.497 | 0
|
LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 11p15.4 | 0.33 | -0.404 | 0
|
KLF2 | Kruppel-like factor 2 | 19p13.11 | 0.328 | -0.467 | 0
|
ICAM3 | intercellular adhesion molecule 3 | 19p13.3-p13.2 | 0.325 | -0.498 | 0
|
ADCY4 | adenylate cyclase 4 | 14q11.2 | 0.324 | -0.481 | 0
|
FAM107A | family with sequence similarity 107, member A | 3p14.2 | 0.319 | -0.41 | 0
|
RASGRP2 | RAS guanyl releasing protein 2 (calcium and DAG-regulated) | 11q13 | 0.318 | -0.49 | 0
|
CD79B | CD79b molecule, immunoglobulin-associated beta | 17q23 | 0.317 | -0.508 | 0
|
GJA4 | gap junction protein, alpha 4, 37kDa | 1p35.1 | 0.315 | -0.526 | 0
|
CCL19 | chemokine (C-C motif) ligand 19 | 9p13 | 0.311 | -0.426 | 0
|
ENG | endoglin | 9q34.11 | 0.311 | -0.476 | 0
|
USHBP1 | Usher syndrome 1C binding protein 1 | 19p13.11 | 0.31 | -0.446 | 0
|
DHX40 | DEAH (Asp-Glu-Ala-His) box polypeptide 40 | 17q22 | 0.31 | 0.467 | 0
|
OCRL | oculocerebrorenal syndrome of Lowe | Xq25 | 0.31 | 0.416 | 0
|
APLNR | apelin receptor | 11q12.1 | 0.296 | -0.451 | 0
|
FCN3 | ficolin (collagen/fibrinogen domain containing) 3 | 1p36.11 | 0.296 | -0.461 | 0
|
TNXB | tenascin XB | 6p21.3 | 0.296 | -0.44 | 0
|
SOX17 | SRY (sex determining region Y)-box 17 | 8q11.23 | 0.295 | -0.469 | 0
|
CETP | cholesteryl ester transfer protein, plasma | 16q13 | 0.291 | -0.447 | 0
|
CUL4B | cullin 4B | Xq23 | 0.29 | 0.392 | 0
|
GADD45G | growth arrest and DNA-damage-inducible, gamma | 9q22.1-q22.2 | 0.289 | -0.291 | 1.1e-09
|
SNRNP48 | small nuclear ribonucleoprotein 48kDa (U11/U12) | 6p24.3 | 0.289 | 0.449 | 0
|
SLC6A10P | solute carrier family 6 (neurotransmitter transporter), member 10, pseudogene | 16p11.2 | 0.284 | 0.389 | 0
|
PIGA | phosphatidylinositol glycan anchor biosynthesis, class A | Xp22.1 | 0.284 | 0.358 | 2.95e-14
|
LGALS2 | lectin, galactoside-binding, soluble, 2 | 22q13.1 | 0.281 | -0.434 | 0
|
PTPN5 | protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) | 11p15.1 | 0.278 | -0.387 | 0
|
GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 3p21.31 | 0.276 | -0.346 | 2.56e-13
|
ETAA1 | Ewing tumor-associated antigen 1 | 2p14 | 0.273 | 0.401 | 0
|
PPFIA4 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | 1q32.1 | 0.271 | 0.508 | 0
|
YEATS2 | YEATS domain containing 2 | 3q27.3 | 0.27 | 0.449 | 0
|
EGLN1 | egl-9 family hypoxia-inducible factor 1 | 1q42.1 | 0.269 | 0.424 | 0
|
ATXN2L | ataxin 2-like | 16p11 | 0.269 | 0.323 | 1.1e-11
|
HK2 | hexokinase 2 | 2p13 | 0.268 | 0.381 | 1.71e-16
|
MXI1 | MAX interactor 1, dimerization protein | 10q24-q25 | 0.265 | 0.488 | 0
|
PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 2q31.1 | 0.259 | 0.425 | 0
|
SERTAD2 | SERTA domain containing 2 | 2p15 | 0.251 | 0.283 | 3.05e-09
|
BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like | 8p21 | 0.25 | 0.38 | 2.22e-16
|
NDRG1 | N-myc downstream regulated 1 | 8q24 | 0.249 | 0.424 | 0
|
NIPA1 | non imprinted in Prader-Willi/Angelman syndrome 1 | 15q11.2 | 0.247 | 0.343 | 4.61e-13
|
ADD2 | adducin 2 (beta) | 2p13.3 | 0.246 | -0.03 | 0.541
|
AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 1q42.2 | 0.245 | -0.337 | 1.1e-12
|
ZNF280B | zinc finger protein 280B | 22q11.2 | 0.245 | -0.033 | 0.493
|
ZNF343 | zinc finger protein 343 | 20p13 | 0.244 | 0.325 | 7.48e-12
|
P4HA1 | prolyl 4-hydroxylase, alpha polypeptide I | 10q22.1 | 0.241 | 0.411 | 0
|
KHSRP | KH-type splicing regulatory protein | 19p13.3 | 0.241 | 0.327 | 5.27e-12
|
SLC6A8 | solute carrier family 6 (neurotransmitter transporter), member 8 | Xq28 | 0.222 | 0.366 | 6.17e-15
|
EGLN3 | egl-9 family hypoxia-inducible factor 3 | 14q12 | 0.221 | 0.379 | 3.54e-16
|
OPA3 | optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) | 19q13.32 | 0.221 | -0.058 | 0.235
|
PFKFB4 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 | 3p22-p21 | 0.215 | 0.289 | 1.43e-09
|
ALDOC | aldolase C, fructose-bisphosphate | 17q11.2 | 0.213 | 0.387 | 0
|
ENO2 | enolase 2 (gamma, neuronal) | 12p13 | 0.212 | 0.381 | 1.69e-16
|
SLC9A3 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | 5p15.3 | 0.196 | 0.272 | 1.24e-08
|